SPP1 and cancer: The multifaceted role of OPN on epithelial and immune cells extends to numerous pathologic conditions, suggesting that optimizing it as a therapeutic target and as a biomarker could have a clinical impact beyond cancer, such as other inflammatory, autoimmune, and chronic conditions.